SREBF1 and atherosclerosis: Consistent with these data, we speculated that enhancing the expression and/or activity of Nur77 in the liver may be beneficial in treating atherosclerosis with regard to its inhibitory effect on SREBP1c and SREBP2 activity and subsequent reduction in lipid accumulation in the liver.